M 944 (Divalproex Sodium Delayed-Release 250 mg)

Pill with imprint M 944 is Blue, Round and has been identified as Divalproex Sodium Delayed-Release 250 mg. It is supplied by Mylan Pharmaceuticals Inc..

Divalproex sodium is used in the treatment of bipolar disorder; mania; migraine prevention; epilepsy and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 944

Divalproex Sodium Delayed-Release

Imprint:

M 944

Strength:

250 mg

Color:

Blue

Size:

11.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Fatty acid derivative anticonvulsants

Pregnancy Category:

D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Mylan Pharmaceuticals Inc.

Inactive Ingredients:

• ferrosoferric oxide
• silicon dioxide
• copovidone
• croscarmellose sodium
• FD&C Blue No. 2
• FD&C Yellow No. 6
• hypromelloses
• lactose monohydrate
• methacrylic acid - ethyl acrylate copolymer (1:1) type a
• microcrystalline cellulose
• polydextrose
• polyethylene glycol
• polysorbate 80
• polyvinyl alcohol
• propylene glycol
• sodium hydroxide
• magnesium silicate
• titanium dioxide
• triacetin
• triethyl citrate

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC Code	Labeler / Repackager
00378-1044	Mylan Pharmaceuticals Inc.
51079-0474	UDL Laboratories Inc.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer